Retatrutide vs Tirzepatide vs Semaglutide — The Triple Agonist Era of GLP-1 Research
A scientific comparison of retatrutide, tirzepatide, and semaglutide across receptor pharmacology, half-life, preclinical findings, and the emerging GLP-1/GIP/glucagon triple-agonist class.
